These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 36872312)

  • 21. Can we predict the development of symptomatic lymphocele following robot-assisted radical prostatectomy and lymph node dissection? Results from a tertiary referral Centre.
    Sforza S; Tellini R; Grosso AA; Zaccaro C; Viola L; Di Maida F; Mari A; Carini M; Minervini A; Masieri L
    Scand J Urol; 2020 Aug; 54(4):328-333. PubMed ID: 32588704
    [No Abstract]   [Full Text] [Related]  

  • 22. A comparative analysis of perioperative complications and biochemical recurrence between standard and extended pelvic lymph node dissection in prostate cancer patients undergoing radical prostatectomy: a systematic review and meta-analysis.
    Ding G; Tang G; Wang T; Zou Q; Cui Y; Wu J
    Int J Surg; 2024 Mar; 110(3):1735-1743. PubMed ID: 38052016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Which lymph node dissection template is optimal for radical cystectomy? A systematic review and Bayesian network meta-analysis.
    Qi W; Zhong M; Jiang N; Zhou Y; Lv G; Li R; Shi B; Chen S
    Front Oncol; 2022; 12():986150. PubMed ID: 36505883
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extended versus standard lymph node dissection for urothelial carcinoma of the bladder in patients undergoing radical cystectomy.
    Hwang EC; Sathianathen NJ; Imamura M; Kuntz GM; Risk MC; Dahm P
    Cochrane Database Syst Rev; 2019 May; 5(5):CD013336. PubMed ID: 31111956
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of extended pelvic lymphadenectomy with radical prostatectomy for high-risk prostate cancer.
    Harbin AC; Eun DD
    Urol Oncol; 2015 May; 33(5):208-16. PubMed ID: 25547974
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of symptomatic lymphoceles after radical prostatectomy and pelvic lymph node dissection is independent of surgical approach: a single-center analysis.
    Thomas C; Ziewers S; Thomas A; Dotzauer R; Bartsch G; Haferkamp A; Tsaur I
    Int Urol Nephrol; 2019 Apr; 51(4):633-640. PubMed ID: 30796729
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pelvic lymph node dissection in prostate cancer.
    Briganti A; Blute ML; Eastham JH; Graefen M; Heidenreich A; Karnes JR; Montorsi F; Studer UE
    Eur Urol; 2009 Jun; 55(6):1251-65. PubMed ID: 19297079
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of lymphoceles after robot-assisted pelvic lymph node dissection.
    Orvieto MA; Coelho RF; Chauhan S; Palmer KJ; Rocco B; Patel VR
    BJU Int; 2011 Oct; 108(7):1185-90. PubMed ID: 21489117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indication for and extension of pelvic lymph node dissection during robot-assisted radical prostatectomy: an analysis of five European institutions.
    Suardi N; Larcher A; Haese A; Ficarra V; Govorov A; Buffi NM; Walz J; Rocco B; Borghesi M; Steuber T; Pini G; Briganti A; Mottrie AM; Guazzoni G; Montorsi F; Pushkar D; Van Der Poel H;
    Eur Urol; 2014 Oct; 66(4):635-43. PubMed ID: 24411992
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of Autologous Fibrin Glue on Lymphatic Drainage and Lymphocele Formation in Extended Bilateral Pelvic Lymphadenectomy in Robot-Assisted Radical Prostatectomy.
    Garayev A; Aytaç Ö; Tavukcu HH; Atug F
    J Endourol; 2019 Sep; 33(9):761-766. PubMed ID: 31187653
    [No Abstract]   [Full Text] [Related]  

  • 31. Lymphangiography and Lymphatic Embolization for the Management of Pelvic Lymphocele After Radical Prostatectomy in Prostatic Cancer.
    Chu HH; Shin JH; Kim JW; Noh SY; Yang WJ; Park S
    Cardiovasc Intervent Radiol; 2019 Jun; 42(6):873-879. PubMed ID: 30919025
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reconsideration on Clinical Benefit of Pelvic Lymph Node Dissection during Radical Prostatectomy for Clinically Localized Prostate Cancer.
    Fujimoto N; Shiota M; Tomisaki I; Minato A; Yahara K
    Urol Int; 2019; 103(2):125-136. PubMed ID: 31039571
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Standardized comparison of robot-assisted limited and extended pelvic lymphadenectomy for prostate cancer.
    Yuh BE; Ruel NH; Mejia R; Novara G; Wilson TG
    BJU Int; 2013 Jul; 112(1):81-8. PubMed ID: 23351148
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of pelvic lymph node dissection and its extent on oncological outcomes in intermediate-risk prostate cancer patients: A multicenter study of the Turkish Uro-oncology Association.
    Izol V; Ok F; Aslan G; Akdogan B; Sozen S; Ozden E; Celik O; Muezzinoglu T; Turkeri L; Akdogan N; Baltaci S
    Prostate; 2022 May; 82(7):763-771. PubMed ID: 35188993
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of symptomatic lymphocele after radical prostatectomy and bilateral pelvic lymph node dissection.
    Gotto GT; Yunis LH; Guillonneau B; Touijer K; Eastham JA; Scardino PT; Rabbani F
    Int J Urol; 2011 Apr; 18(4):291-6. PubMed ID: 21306438
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Applied anatomy of pelvic lymph nodes and its clinical significance for prostate cancer:a single-center cadaveric study.
    Chen JJ; Zhu ZS; Zhu YY; Shi HQ
    BMC Cancer; 2020 Apr; 20(1):330. PubMed ID: 32299388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Peritoneal Interposition Flap on Patients Undergoing Robot-assisted Radical Prostatectomy and Pelvic Lymph Node Dissection: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
    May M; Gilfrich C; Bründl J; Ubrig B; Wagner JR; Gloger S; Student V; Merseburger AS; Thomas C; Brookman-May SD; Wolff I
    Eur Urol Focus; 2024 Jan; 10(1):80-89. PubMed ID: 37541915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Extended pelvic lymph node dissection including internal iliac packet should be performed during robot-assisted laparoscopic radical prostatectomy for high-risk prostate cancer.
    Jung JH; Seo JW; Lim MS; Lee JW; Chung BH; Hong SJ; Song JM; Rha KH
    J Laparoendosc Adv Surg Tech A; 2012 Oct; 22(8):785-90. PubMed ID: 22967037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Can Negative Prostate-specific Membrane Antigen Positron Emission Tomography/Computed Tomography Avoid the Need for Pelvic Lymph Node Dissection in Newly Diagnosed Prostate Cancer Patients? A Systematic Review and Meta-analysis with Backup Histology as Reference Standard.
    Stabile A; Pellegrino A; Mazzone E; Cannoletta D; de Angelis M; Barletta F; Scuderi S; Cucchiara V; Gandaglia G; Raggi D; Necchi A; Karakiewicz P; Montorsi F; Briganti A
    Eur Urol Oncol; 2022 Feb; 5(1):1-17. PubMed ID: 34538770
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No difference in six-year biochemical failure rates with or without pelvic lymph node dissection during radical prostatectomy in low-risk patients with localized prostate cancer.
    Bhatta-Dhar N; Reuther AM; Zippe C; Klein EA
    Urology; 2004 Mar; 63(3):528-31. PubMed ID: 15028451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.